Papers
6
Total Citations
61
H-Index
3
About
Dr. Grant Henning is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly through the application of single-port (SP) and multi-port robotic platforms. His major contributions lie in refining robot-assisted radical prostatectomy (RARP) and renal surgery, with a focus on improving functional outcomes while maintaining oncologic efficacy. In a landmark 2022 study (24 citations), he demonstrated that Retzius-sparing single-port RARP yields superior early continence and potency compared to extrapelvic and transperitoneal approaches, offering a paradigm shift in patient selection for SP surgery. His 2023 analysis of single-port versus multi-port renal surgery (20 citations) further established the safety and efficacy of SP platforms across varying tumor complexities. Dr. Henning has also advanced the field through technical innovations, including the first description of single-port robot-assisted radical cystectomy with intracorporeal diversion (2021) and a novel Retzius-sparing technique using the da Vinci SP robot (2021). His work on symptomatic lymphocele rates after Retzius-sparing prostatectomy (2020, 9 citations) and a rare case of malignant mesothelioma of the tunica vaginalis (2016) underscores his breadth in addressing both common and uncommon urologic pathologies. With over 60 citations across his most influential works, Dr. Henning is shaping the next generation of robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates9 citations · 2020
- 4
- 5
- 6